glp-1's GLP-1 Medications: Everything You Need to Know Comparing Ozempic, Wegovy and Other

Minamino, D

AM833, an investigational human amylin analog formulated for once weekly administration, has been assessed in short-term clinical studies in human subjects with obesity with or without co-administration of once-weekly semaglutide

Zhang H, Song B, Zhu W, Liu L, He X, Wang Z, et al

Rather than suppressing caloric intake, they may enhance substrate utilization, preserve lean mass, and improve metabolic resiliencefeatures particularly relevant to aging populations, where sarcopenia, osteoporosis, and insulin resistance frequently coexist

Owens has since lost 150 pounds and no longer has high blood pressure, high cholesterol, insulin resistanceor the urge to binge